Drug Approval | December 10, 2021
Dr Reddy’s launch Venlafaxine ER tablets in the US
The tablets are available in 150 mg and 225 mg strengths in bottle count sizes of 30 and 90.
The tablets are available in 150 mg and 225 mg strengths in bottle count sizes of 30 and 90.
Gland Pharma believes that they are amongst one of the first to file for this product and may be eligible for 180 days of generic drug exclusivity
Dr. Reddy's valsartan tablets, USP are available in 40 mg in bottle count size of 30, and 80 mg, 160 mg and 320 mg tablets in bottle count sizes of 90
This is the fourth facility from the company to receive this registration
The investigational compound, GZR18, is a novel analogue of glucagon-like peptide-1 (GLP-1), an incretin hormone responsible for many glucoregulatory effects
The product will be commercialized from Unichem's Ghaziabad plant
The Indian medical devices industry has been in focus since the pandemic. From US $ 11 billion in 2020 it is expected to touch US $ 50 billion by 2025. Mehernosh Daruwalla, Founder and MD, Lotus Surgicals shares a perspective with Thomas C Thottathil on the opportunities in this sector
The ANDA has been co-developed in partnership with Orbicular Pharmaceutical Technologies
If approved or authorized, Paxlovid would be the first oral antiviral of its kind, to combat SARS-CoV-2
The cream has an estimated market size of US $ 28 million for twelve months ending Jun 2021 according to IQVIA
Subscribe To Our Newsletter & Stay Updated
